Clinical trial
Early Oral Switch Versus Intravenous Antibiotics in Previously Healthy Children and Adolescents With Bloodstream Infections
NCT07791914 is registered in ClinicalTrials.gov with Ulrikka Nygaard as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Oral Switch Versus Intravenous Antibiotics in Previously Healthy Children and Adolescents With Bloodstream Infections
- Lead sponsor
- Ulrikka Nygaard
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- September 1, 2026
- Completion date
- November 1, 2029
- Enrollment
- 150 (estimated)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.
bacteremia sepsis, bloodstream infection